Autopsy report · NCT03471559

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Two step study, step two was not feasible based on results from phase one.”

The sponsor’s own words in the registry.

Life of this trial

Registered 9 months before it started.
Ran for about 9 months before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Central Institute of Mental Health, Mannheim
Sponsor type: University, hospital or other
Conditions: Pharmacokinetics, Bioavailability
Interventions: Cannabidiol
Participants: 8
Sites: 1
Countries: Germany

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.